Results per Page:

Crunching the numbers for next-gen COVID-19 vaccines
BARDA taps Fred Hutch biostatisticians to assess new vaccine technology, more nimble trial design

For Fred Hutch biostatisticians, numbers are no game
Meticulous work at the SWOG Statistics and Data Management Center, housed at Fred Hutch, may alter care for bladder cancer and lymphoma

Risky business: Understanding how numbers, percentages and data impact cancer care
Statistics can simultaneously enlighten and confuse patients

Digging into the math ‘behind the screens’ of cancer surveillance
From the Etzioni Lab, Public Health Sciences Division

Fred Hutch’s Dr. Ross Prentice retires
Longtime scientist and statistician contributed to Women’s Health Initiative, cancer prevention research and much more

How to “ConQuR” batch effects in microbiome data
From the Wu and Randolph Labs, Biostatistics and Computational Biology Program, Cancer Consortium.

Empirical Approach to HEI scores in postmenopausal women
From the Nutrition and Physical Assessment Study (NPAAS) Group, Public Health Sciences Division

Dr. Yingye Zheng named fellow of American Statistical Association
Honored for work to develop biomedical decision tools

5 reasons why a cancer research center has virology expertise
Pathogens can cause diseases, the immune system can fight them

Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news

Biostatisticians draft blueprints for COVID-19 vax trials
Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic

Dr. Ruth Etzioni receives Rosalie & Harold Rea Brown Endowed Chair
'Biostatistician on a mission' uses math models to improve cancer screening, reduce health disparities

Spinning science: Overhyped headlines, snarled statistics lead readers astray
Tips and tools to help you better understand cancer risk, scientific research and clinical studies

99 problems when n=1?
In research, (sample) size matters

Dr. M. Elizabeth ‘Betz’ Halloran elected to National Academy of Medicine
Statistician honored for helping the world anticipate, manage and prevent infectious disease outbreaks

Structural and clinical barriers keep 3 of 4 cancer patients from participating in trials
‘Patients are willing to participate in trials if they’re offered one’

Bringing personalized oncology to cancer prediction — and prevention
Unique $2.4M NCI-NIEHS award teams Hutch cancer geneticists, epidemiologists and oncologists to use mutation rate to predict individual cancer risk

Dr. James Dai receives $2.1M NCI grant for cancer biomarker research
Biostatistician plans to use funds to develop statistical models to further precision cancer prevention and treatment

Dr. Yingqi Zhao receives SWOG Coltman Fellowship early-career award
She plans to use the funds to develop new surveillance and diagnostic strategies for immunotherapy trials

Harnessing the power of genetics to improve transplant safety
From the Petersdorf Group, Clinical Research Division